A Replication-Competent Vesicular Stomatitis Virus for Studies of

Description

Frontiers Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019

Development of recombinant vesicular stomatitis virus vaccine platform for rapid response to Ebola and COVID-19 outbreaks

Indiana vesiculovirus - Wikipedia

Viruses, Free Full-Text

Long-term passaging of replication competent pseudo-typed SARS-CoV-2 reveals the antiviral breadth of monoclonal and bispecific antibody cocktails

Viruses, Free Full-Text

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates

Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice - ScienceDirect

Structure of the Vesicular Stomatitis Virus L Protein in Complex with Its Phosphoprotein Cofactor - ScienceDirect

Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months - American Journal of Transplantation